{"id":102372,"date":"2024-10-29T08:12:00","date_gmt":"2024-10-29T11:12:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/2one-labs-receives-pmta-acceptance-for-2one-nicotine-pouch-brand-from-fda-center-for-tobacco-products\/"},"modified":"2024-10-29T08:12:00","modified_gmt":"2024-10-29T11:12:00","slug":"2one-labs-receives-pmta-acceptance-for-2one-nicotine-pouch-brand-from-fda-center-for-tobacco-products","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/2one-labs-receives-pmta-acceptance-for-2one-nicotine-pouch-brand-from-fda-center-for-tobacco-products\/","title":{"rendered":"2ONE Labs Receives PMTA ‘Acceptance’ for 2ONE\u00ae Nicotine Pouch brand from FDA Center for Tobacco Products"},"content":{"rendered":"

2ONE LABS INC.<\/b><\/p>\n

LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc.,\u00a0<\/strong>is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its 2ONE\u00ae\u00a0branded nicotine pouches.<\/p>\n

Acknowledging receipt of the FDA Acceptance notification, Vincent Schuman, CEO of 2ONE Labs, said: This means the 2ONE\u00ae PMTA application will now move forward to the next important stage of FDA review. Our company will continue to fully fund this submission to a successful conclusion, and our wholesale, retail and\u00a0sponsorship partners should take confidence in this\u00a0Acceptance as a sign of our ability to navigate this complex PMTA process, and of our unwavering commitment to support the long-term availability of the 2ONE\u00ae brand in the US market.<\/p>\n

Schuman added: We created 2ONE\u00ae\u00a0nicotine pouches for adult users (21+), who find it challenging to switch from combustible or traditional oral tobacco-leaf products. The availability of the 2ONE\u00ae brand in the market over the past 5 years, and the interest and growth our brand has achieved through strong retail partnerships,\u00a0such as with CircleK\u00ae, has shown it is possible – even for innovative companies – to identify and introduce unique brands that truly offer adults the perfect switching product. We are encouraged by FDAs acceptance of the 2ONE\u00ae PMTA submission and we look forward to continuing to support the needs of adult consumers switching from tobacco.<\/p>\n

2ONE\u00ae nicotine pouch products are offered in a variety of nicotine levels and satisfying flavors at over 18,000 retail outlets nationwide, and can be purchased online by adult consumers at: 21Pouches.com.<\/p>\n

About 2ONE\u00ae Nicotine Pouches<\/strong><\/p>\n

2ONE Labs Inc.: Founded by pioneers in synthetic nicotine production, 2ONE Labs specializes in providing the most innovative tobacco-free nicotine products to adult consumers seeking an alternative to other tobacco products. For more information, contact\u00a021Pouches.com<\/a>. 2ONE\u00ae is a registered trademark of 2ONE Labs Inc., Lake Tahoe, NV. All Rights Reserved.<\/p>\n

Source: 2ONE LABS INC.<\/p>\n

Contact:
Vincent@21pouches.com<\/p>\n



\n\"Primary<\/a><\/p>\n

A OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP<\/b> e sao de inteira responsabilidade da GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc.,\u00a0is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product Application (PMTA) submission","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-102372","post","type-post","status-publish","format-standard","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/102372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=102372"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/102372\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=102372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=102372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=102372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}